🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to BioTechX Europe — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
BioTechX Europe 2026 (Basel) — Buyer & Audience Research Brief
Event Snapshot (from official event source)
- Event name: BioTechX 2026 / BioTechX Europe
- Dates: 6 - 8 October 2026
- Venue: Messe Basel
- City & Country: Basel, Switzerland
- Event positioning: Data, AI, Discovery, Healthcare (life sciences and biotech ecosystem)
- Stated scale: 3000+ attendees, 400+ speakers, 150+ exhibitors, 100+ biotech start-ups
What BioTechX Europe is (context for buyer targeting)
BioTechX is a converged marketplace that connects multiple verticals across the biotech and pharmaceutical ecosystem—covering areas such as drug discovery, clinical trials, R&D, data science, digital transformation, AI, and genomics breakthroughs. The conference brings together pharma leaders, tech pioneers, investors, solution providers, and research organizations. For attendee-list planning and buyer-fit research, that means we typically see a mix of: (1) decision-makers from pharma/biotech and research groups, (2) product and commercial leaders from diagnostics/data/AI companies, and (3) enterprise transformation leaders who care about data integration and translational workflows.
1️⃣ Who attends (BUYERS / ATTENDEES)
This event is not limited to one type of buyer. Based on the described ecosystem scope (drug discovery, clinical trials, R&D, data science, AI, genomics), the strongest buyer segments we expect are professionals who influence technology adoption, research strategy, data platforms, analytics, and partnerships that accelerate drug development. In practice, “buyers” at BioTechX Europe usually cluster into several attendee groups:
A) Pharma & Biotech decision-makers (core buyers)
- Therapeutic area and medical affairs leadership who evaluate evidence generation and digital/precision medicine capabilities
- R&D leaders who define roadmaps for discovery, clinical research workflows, biomarker programs, and genomics strategy
- Data, AI, and digital transformation leaders who own data integration, governance, and platform architecture
B) Diagnostics & genomics & data-analytics buyers (solution-adoption buyers)
- Heads of genomics, biostatistics, data science, and advanced analytics
- Leads responsible for real-world and trial data, biomarker computation, and patient stratification
- Operational leaders who evaluate lab/clinical informatics and identity/data integration approaches
C) Technology, AI, and digital transformation ecosystem (technology commerce buyers)
- Commercial and partnership leaders who sell platforms, services, and solutions to pharma/biotech
- Enterprise transformation and program owners who implement workflow automation and data transformation
D) Investors, partner networks, and ecosystem builders (deal-enablement buyers)
- Investment and corporate development stakeholders
- Leaders who sponsor collaboration programs, start-up partnerships, and co-development initiatives
2️⃣ Where the show is happening + attendee geographic origin
Show location
Messe Basel, Basel, Switzerland
Attendee geographic origin (expected)
BioTechX Europe is positioned as a European event anchored in Switzerland, with a global life-sciences value chain represented in speakers and major participants. We expect the strongest concentration of attendees from:
- Europe: Switzerland, UK, Germany, France, Netherlands, Nordics, and broader EU research hubs
- North America: companies and investors with global clinical and R&D footprints
- Rest of world: selective participation from Asia-Pacific and emerging biopharma ecosystems, especially via digital/data/AI and genomics collaborations
For targeting, we recommend building a buyer list with a “Europe-first + global leadership” structure: Europe for density and relevance, plus global decision-makers for cross-border dealmaking.
3️⃣ Audience reach (Local / National / Global)
Primary reach: Global (Europe-centered). The event’s stated positioning—connecting every vertical across the biotech and pharmaceutical ecosystem—plus references to global pharma and research organizations indicates we should treat this as an international buyer gathering rather than a purely local show. Practically, the buyer density is typically highest in Europe due to regional company presence, but the attendee quality and business interest are international.
4️⃣ Sample buyer company names (BUYERS ONLY) + websites
Below are buyer-style target accounts we would prioritize based on the event’s themes (diagnostics, precision medicine, data/AI, genomics, clinical and R&D transformation). These are the types of organizations we typically see as buyers or evaluation stakeholders for data/AI, discovery, medical affairs, and genomics programs.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Roche | https://www.roche.com | Global Therapeutic Area Head (Medical Affairs) / Head of Digital Transformation | Strong fit across medical affairs, immunology/infectious disease priorities, and digital transformation for data-driven healthcare and R&D. |
| 2 | Novartis | https://www.novartis.com | Chief Data & Digital Officer (Biomedical Research) / Head of Operational Data Insights | Direct relevance to AI/data integration, biomedical research data strategy, and discovery/clinical acceleration. |
| 3 | Bayer | https://www.bayer.com | Chief Data & Digital Officer Biomedical Research / VP R&D Data Science & AI | Fit for genomics, data science, behavioral science/AI, and translational research programs. |
| 4 | Sanofi | https://www.sanofi.com | Head of Smart Factory / Head of Biostructure and Biophysics | Strong alignment with digital transformation of R&D operations and advanced discovery capabilities. |
| 5 | UCB | https://www.ucb.com | SVP Global Asset Head (Neuroinflammation and Rare Diseases) | Fit for precision medicine and data-led discovery/asset strategy within therapeutic development. |
| 6 | Boehringer Ingelheim | https://www.boehringer-ingelheim.com | Global Head Biostatistics & Data Science | Direct relevance to biostatistics, advanced analytics, trial data strategy, and AI-driven research execution. |
| 7 | Sandoz | https://www.sandoz.com | Head of Behavioral Science & Data Science | Good fit for applied AI/data science in patient-centered insights and evidence generation. |
| 8 | Novo Nordisk | https://www.novonordisk.com | Vice President, Operational Data Insights | Strong alignment to operational analytics, data platforms, and scaling data integration for research and healthcare delivery. |
| 9 | Recordati | https://www.recordati.com | Head of Medical Excellence & Communications | Likely buyer interest for medical excellence programs that connect clinical insights with digital transformation and evidence strategy. |
| 10 | Cilcare | https://www.cilcare.com | CFO & Chief Digital Officer | Good fit as a digital leader/operator supporting life-science solutions and transformation roadmaps. |
| 11 | Our Future Health | https://www.ourfuturehealth.org.uk | Chief Business Officer | Relevant for large-scale data initiatives and partner ecosystems that support discovery and patient-centric research. |
| 12 | Foresite Labs | https://www.foresite.com | SVP and Head of Genomics | Excellent fit for genomics and discovery platforms, especially where AI/data interpretation is central. |
| 13 | UCB (life sciences assets) | https://www.ucb.com | SVP Global Asset Head / Translational Strategy Lead | Buyer fit for rare diseases/neuroinflammation development strategies requiring precision medicine and data-led decisioning. |
| 14 | Novartis AG | https://www.novartis.com | Chief Data & Digital Officer Biomedical Research / Program Lead, Data Transformation | Direct alignment to biomedical research data strategy and AI/data governance for discovery and clinical development. |
| 15 | Digital transformation partner (corporate sponsor category) | (placeholder; confirm based on client product) | Enterprise Transformation Director / VP Data Platforms | We tailor these entries after we review the client website, to ensure we target the exact buyer type for the solution category. |
| 16 | AI / data solution provider (life sciences) | (placeholder; confirm based on client product) | VP Product / Head of Partnerships / Data Platform Buyer | We replace placeholders with specific buyer accounts after we confirm what is sold (platform, service, dataset, diagnostics, etc.). |
| 17 | Genomics & precision medicine developer | (placeholder; confirm based on client product) | Head of Precision Medicine / Director of Genomics Strategy | We use the event’s theme alignment to select buyer organizations that evaluate genomics/AI workflows and clinical translation paths. |
| 18 | Clinical data & trial analytics platform buyer | (placeholder; confirm based on client product) | Head of Clinical Data / Biostatistics Lead / Head of Trial Analytics | We include only companies whose business function matches the buyer decision path for clinical and R&D analytics. |
| 19 | Diagnostics & evidence generation buyer | (placeholder; confirm based on client product) | Director of Diagnostic Strategy / VP Medical Affairs Analytics | We target diagnostic/evidence buyers if the client product supports diagnostics validation, companion diagnostics, or precision stratification. |
| 20 | Data integration / healthcare interoperability buyer | (placeholder; confirm based on client product) | Chief Data Officer / Head of Data Integration (Life Sciences) | We target enterprise data platform and integration stakeholders when the client solution addresses data unification and interoperability. |
Top buyer priorities to start with: Roche, Novartis, Bayer, Sanofi, UCB, Boehringer Ingelheim. These map tightly to the event’s themes and speaker/buyer ecosystem style described on the official page.
5️⃣ Job profiles, industries & event type
Best job profiles to target (buyer-focused)
We focus on roles that typically own evaluation budgets, platform decisions, and evidence generation roadmaps across data/AI and biotech R&D:
- Chief Data & Digital Officer (Biomedical Research)
- Group Lead Digital Transformation / Digital Transformation Lead
- Global Head Biostatistics & Data Science
- VP R&D Data Science & AI
- Head of Genomics / Genomics Strategy Lead
- Vice President, Operational Data Insights
- Medical Affairs Therapeutic Area Leadership (e.g., Global Therapeutic Area Head)
- SVP Global Asset Head (Rare Diseases / Specialty Therapeutic Areas)
- Head of Smart Factory / R&D operational modernization roles
- Chief Digital Officer / CFO & Chief Digital Officer (for transformation and ROI governance)
- Chief Business Officer (for partnership and ecosystem expansion)
- Operational strategy and partnership roles connected to data integration, discovery pipelines, and AI adoption
Industries most aligned with this show (from the provided industry list)
We would filter and prioritize the following industries most heavily for buyer account discovery:
- Pharmaceuticals
- Biotechnology
- Health, Wellness & Fitness (only where relevant to healthcare innovation/digital health programs)
- Hospital & Health Care
- Medical Devices (if the solution supports diagnostics/clinical workflows)
- Information Technology & Services
- Computer Software
- Information Services
- Research
- Market Research (only for evidence/analytics use-cases)
- Professional Training & Coaching (only if the solution is training/enablement for data/AI teams)
- Marketing & Advertising (rarely primary here; used only if the client sells commercialization services for digital health/AI products)
Event type (how we classify it)
- Conference with an exhibit ecosystem (150+ exhibitors)
- Focus on precision medicine, diagnostics, data science, AI, and genomics breakthroughs
- Strong emphasis on digital transformation and accelerating drug development
6️⃣ Estimated attendance (expected total footfall)
The official event listing states 3000+ attendees and 3 days at Messe Basel. For planning purposes, we estimate:
- Expected total footfall: 3000+ total attendees across 3 days (some repeat attendance likely for key sessions)
- Exhibitor audience size: 150+ exhibitors plus 100+ biotech start-ups, increasing the probability of high-intent buyer conversations during expo hours
- Speaker density: 400+ speakers, suggesting broad coverage of multiple subtopics (data integration, AI, genomics, clinical research transformation, and precision medicine)
For buyer-list strategies, we treat this as a high-quality international B2B audience with strong relevance to technology adoption and partnership evaluation in life sciences.
7️⃣ Key focus areas & buyer engagement
Key focus areas (from the official positioning)
- Diagnostics
- Precision medicine
- Digital transformation
- AI and data-driven discovery
- Data integration and enabling drug development workflows
- Genomics breakthroughs
- Drug discovery, clinical trials, and R&D acceleration
How buyers are likely to engage
- Solution evaluation conversations: we expect structured discussions on how platforms/services improve trial efficiency, data quality, and decision-making.
- Partnership and co-development networking: the presence of start-ups and investor-oriented ecosystem dynamics creates high engagement for partnership-ready organizations.
- Workshop-style learning and technical sessions: high speaker count suggests deep technical talks that attract practitioners and decision-makers.
- Theme-based meetings: we recommend routing outreach based on whether a buyer is focused on discovery, clinical analytics, genomics, or enterprise data transformation.
8️⃣ Client-product fit & buyer recommendation (We need your website)
To identify the best buyer accounts for your specific requirements, we need to review the client product exactly as it is positioned on its website. Please share your client website URL (and, if possible, 1–2 lines describing what the product does).
Once we have the client website, we will do the following:
- Map your product category to the event’s buying themes (diagnostics / precision medicine / genomics / AI & data / digital transformation / clinical trial enablement)
- Select only the buyers whose job functions align with your decision pathway (data, genomics, clinical analytics, medical affairs, R&D transformation, partnerships)
- Remove “near misses” (companies that attend but typically don’t buy in your product category)
- Return a prioritized buyer list with target job titles and the closest-fit industry filters from the provided industry list
Quick checklist (optional but helpful): Are we selling a platform, a service, a dataset, diagnostics tooling, AI software, or consulting/implementation? Also confirm target buyer geography (Europe only vs. global) and deal size range if applicable.
9️⃣ Final recommendation (Is BioTechX Europe a good fit for attendee/buyer research?)
Yes—BioTechX Europe 2026 is strongly aligned for buyer-focused research and targeting. The event’s theme (data/AI/discovery/precision medicine/genomics) and scale (3000+ attendees; 150+ exhibitors; 100+ start-ups; 400+ speakers) indicate a high concentration of life sciences stakeholders who evaluate technology, data solutions, and partnership opportunities that accelerate drug development.
The best approach for highest response is to build the buyer list around:
- Data & AI transformation decision-makers (Chief Data/Chief Digital / Digital Transformation leads)
- Genomics and biostatistics leadership (Heads and VPs of genomics, biostatistics, data science)
- Medical affairs and therapeutic area leadership roles that influence precision medicine and evidence strategy
- R&D and operational modernization roles connected to discovery pipelines and AI-enabled research
What we need from you to finalize the “best buyers”
Please share your client website. After our review, we will return the most relevant buyer companies and titles for BioTechX Europe 2026 based on your product requirements.
Data sheet
BioTechX Europe – Event Attendee & Buyer Profile Analysis
Event Date: 6–8 October 2026
Location: Messe Basel, Basel, Switzerland
Event Status: Upcoming
Research Date: 30 June 2026
Event Overview
| Event Name | BioTechX Europe 2026 |
| Event Date | 6–8 October 2026 |
| Event Status | Upcoming |
| Venue | Messe Basel |
| City | Basel |
| State / Region | Basel-Stadt |
| Country | Switzerland |
| Organizer | Terrapinn |
| Official Event Website | BioTechX Europe 2026 by Terrapinn |
| Event Type | Conference, exhibition, startup showcase, sponsorship and networking event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | IT & Technology; Science & Research; Business Services |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | 3,000+ attendees (organizer-reported) |
| Attendance Data Reliability | Confirmed by organizer on official event page |
| Main Purpose of Event | To connect biotech, pharma, diagnostics, data, AI, precision medicine, and digital transformation stakeholders for learning, partnership, sourcing, and commercial engagement. |
About the Event
BioTechX Europe is a major life sciences conference and exhibition focused on diagnostics, precision medicine, digital transformation, AI, data, genomics, drug discovery, and clinical innovation. The official event positioning emphasizes a cross-ecosystem marketplace where pharmaceutical leaders, biotech innovators, technology providers, investors, and research organizations can meet, learn, and collaborate.
The event matters because it sits at the intersection of scientific R&D and commercial deployment, making it highly relevant for procurement, strategic partnerships, technology evaluation, and innovation sourcing. Its participant mix suggests strong relevance for decision-makers in pharma, biotech, diagnostics, health data, and digital health who influence vendor selection, supplier partnerships, and transformation initiatives.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| R&D / Discovery Leaders | Pharma, biotech, CROs, translational research groups | Influence on platform selection, research tools, and collaboration models | High-value for AI, data, lab tech, assay, and workflow vendors |
| Clinical Development / Trials Teams | Pharma sponsors, CROs, clinical ops providers | Evaluate data platforms, trial tech, site services, and partners | Relevant for eClinical, data, patient recruitment, and trial analytics suppliers |
| Digital Transformation / IT Leaders | Pharma, diagnostics, health-tech, research institutions | Own technology roadmaps, system integration, and vendor evaluation | Strong fit for software, cloud, AI, data governance, and cybersecurity vendors |
| Data Science / Bioinformatics Leaders | Biotech, pharma, genomics, research labs | Select platforms, analytics tools, and data partnerships | Highly relevant for AI, genomics, data engineering, and HPC vendors |
| Procurement / Strategic Sourcing | Pharma companies, biotech firms, diagnostics organizations | Own sourcing, contract negotiation, and supplier onboarding | Important for suppliers of lab services, software, equipment, and outsourced capabilities |
| Medical Affairs / Scientific Affairs | Pharma, biotech, medtech, health systems | Influence evidence generation, clinical communications, and expert networks | Relevant for medical communications, real-world evidence, and knowledge platforms |
| Investors / Corporate Development | VC, corporate venture, pharma innovation teams | Assess pipelines, partnerships, and market opportunities | Relevant for innovation scouts, deal-flow, and startup ecosystem targeting |
| Startup Founders / Business Development | Biotech startups, digital health startups, AI tool providers | Seek partnerships, distribution, pilots, and investment | Useful for partner acquisition and channel development |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Basel / Host City | Local pharma, biotech, research, and services ecosystem | High | Basel is a major life sciences hub with strong pharma concentration. |
| Switzerland | National biotech, pharma, medtech, and research stakeholders | High | Strong domestic reach due to Zurich, Basel, and Geneva life sciences ecosystems. |
| Nearby business hubs | Southern Germany, France, Benelux, North Italy | High | Accessible cross-border attendance for pharma and research decision-makers. |
| Europe | Pharma, biotech, diagnostics, health data, investment, and startup communities | Very High | Official positioning and speaker mix indicate broad European reach. |
| Global | Multinational pharma, biotech, health-tech, and research organizations | High | The conference content and speaker roster show international participation potential. |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official page positions BioTechX as a cross-border life sciences marketplace with global leaders, innovators, and pharma stakeholders. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Novartis AG | Pharma buyer / enterprise stakeholder | Officially referenced on the event page; major pharma decision-maker for data, AI, and R&D transformation. | novartis.com | Chief Data Officer, VP R&D, Procurement Director, Digital Transformation Lead | Confirmed Speaker Organization |
| Roche | Pharma / diagnostics buyer | Strong fit for diagnostics, medical affairs, AI, data, and digital transformation solutions. | roche.com | Head of Data Science, IT Director, Medical Affairs Lead, Procurement Manager | Confirmed Speaker Organization |
| Bayer AG | Pharma / life sciences buyer | Relevant for R&D data, AI, clinical innovation, and research platform sourcing. | bayer.com | VP R&D Data & AI, Category Manager, Innovation Director | Confirmed Speaker Organization |
| Sanofi | Pharma buyer | Large global pharma with interest in digital, AI, smart factory, and data-enabled operations. | sanofi.com | Head of Smart Factory, Operations Director, Digital Lead | Confirmed Speaker Organization |
| Novo Nordisk | Pharma buyer | Relevant for operational data, evidence generation, and digital health partnerships. | novonordisk.com | Head of Data Insights, Procurement Lead, Program Manager | Confirmed Speaker Organization |
| Boehringer Ingelheim | Pharma buyer | Suitable target for biostatistics, data science, and R&D workflow solutions. | boehringer-ingelheim.com | Head of Biostatistics, Procurement Director, R&D Operations Lead | Confirmed Speaker Organization |
| UCB | Biopharma buyer | Relevant for asset strategy, clinical development, and innovation partnerships. | ucb.com | SVP Global Asset Head, Business Development Director, Procurement Manager | Confirmed Speaker Organization |
| Recordati | Pharma buyer | Good fit for medical affairs, communications, and digital enablement vendors. | recordati.com | Head of Medical Excellence, Medical Affairs Director, Partnerships Lead | Confirmed Speaker Organization |
| Sandoz | Pharma buyer | Relevant for data science, behavioral science, and commercial transformation. | sandoz.com | Head of Data Science, Commercial Operations Director, Procurement Lead | Confirmed Speaker Organization |
| Foresite Labs | Biotech / data innovation buyer | Strong fit for AI, genomics, and discovery-tech partnerships. | foresitelabs.com | SVP Genomics, Head of AI Research, Partnerships Director | Confirmed Speaker Organization |
| Our Future Health | Health research / data buyer | Relevant for population health, data platforms, and research collaboration. | ourfuturehealth.org.uk | Chief Business Officer, Data Partnerships Lead, Program Director | Confirmed Speaker Organization |
| Cilcare | Biotech buyer | Potential buyer for research tools, data platforms, and partnership opportunities. | cilcare.com | CFO, Chief Digital Officer, Business Development Lead | Confirmed Speaker Organization |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Data Officer | Data / Digital | C-Level | Owns enterprise data strategy, governance, and analytics procurement. |
| 2 | VP R&D / Head of Research | Research & Development | VP / SVP | Drives platform choices for discovery, translational science, and innovation programs. |
| 3 | Procurement Director | Procurement | Director | Owns sourcing and vendor selection for services, platforms, and equipment. |
| 4 | Director of Digital Transformation | Digital / IT | Director | Evaluates AI, automation, integration, and workflow modernization. |
| 5 | Head of Bioinformatics | Bioinformatics / Research IT | Head / Director | Key buyer for genomics, AI, and computational biology tools. |
| 6 | Clinical Operations Director | Clinical Development | Director | Influences trial tech, operational platforms, and vendor selection. |
| 7 | Medical Affairs Director | Medical Affairs | Director | Relevant for evidence generation, content, and stakeholder engagement solutions. |
| 8 | Head of Smart Manufacturing / Factory | Operations / Manufacturing | Head / Director | Interested in digital operations, automation, and process intelligence. |
| 9 | Strategic Sourcing Manager | Procurement | Manager | Handles category-level vendor evaluation and sourcing events. |
| 10 | Business Development Director | Partnerships / Corporate Development | Director | Seeks partnerships, licensing, pilots, and commercialization routes. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Core audience for drug discovery, development, and digital pharma transformation | Enterprise pharma buyers, R&D, data, and procurement |
| 2 | Biotechnology | Central to biotech startups, translational science, and platform buyers | Innovation, partnership, and startup targeting |
| 3 | Information Technology & Services | Relevant for digital transformation, integration, and enterprise platforms | IT decision-makers and platform buyers |
| 4 | Computer Software | Strong fit for AI, analytics, workflow, and lab software providers | Software evaluation and pilot acquisition |
| 5 | Medical Devices | Relevant for diagnostics, clinical instrumentation, and connected devices | Product, commercial, and procurement stakeholders |
| 6 | Research | Conference content is research-led across genomics, discovery, and precision medicine | Research leaders and academic-industry collaboration |
| 7 | Hospital & Health Care | Relevant for clinical adoption, diagnostics, and health systems partnerships | Medical affairs, systems, and digital health buyers |
| 8 | Biotechnology | Strong startup and platform ecosystem presence | Founder, BD, and innovation targeting |
| 9 | Marketing & Advertising | Useful for medcomms, scientific communications, and conference content vendors | Communications and engagement buyers |
| 10 | Management Consulting | Advisory firms support transformation, digital, and operating-model change | Advisory, implementation, and strategic partnership targeting |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 3,000+ attendees | Confirmed | Official event page | Organizer-reported attendance figure. |
| Exhibitor count | 150+ exhibitors | Confirmed | Official event page | Supports strong B2B prospecting potential. |
| Biotech start-ups | 100+ | Confirmed | Official event page | High-value for innovation scouting and partnership outreach. |
| Speaker count | 400+ | Confirmed | Official event page | Large speaker volume supports account mapping and name-list enrichment. |
| Sponsor count | Not publicly confirmed | Unconfirmed | Official page reviewed | Sponsor volume not separately stated in the provided content. |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Diagnostics | Test accuracy, speed, and scalability | Vendor demos, product comparisons, clinical validation discussions | Diagnostics platforms, instruments, reagents, analytics |
| Precision Medicine | Patient stratification and biomarker workflows | Partnership and pilot conversations with clinical stakeholders | Biomarker, genomics, and evidence-generation tools |
| AI / Data | Data integration, model development, governance | Executive meetings with digital and data leaders | AI platforms, analytics, MLOps, data infrastructure |
| Genomics | Sequencing, interpretation, and research acceleration | Scientific networking and workflow optimization discussions | Genomics platforms, bioinformatics, cloud compute |
| Drug Discovery | Faster target identification and validation | Innovation scouting and supplier qualification | Discovery software, lab automation, services |
| Clinical Trials | Operational efficiency and data quality | Vendor meetings with clinical ops and procurement teams | eClinical tools, site services, trial analytics |
| Digital Transformation | System modernization and workflow automation | IT and operations decision-maker outreach | Enterprise software, integration, automation, cloud |
| Partnerships & Investment | Commercial collaboration and growth | BD, corporate development, and investor meetings | Platform partnerships, pilots, and co-development |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event strongly aligns with pharma, biotech, diagnostics, data, and AI buyers. |
| Decision-maker availability | High | Speaker roster and agenda indicate senior-level participation across functions. |
| Data collection potential | High | Large attendee, exhibitor, and speaker base supports prospecting and list enrichment. |
| Apollo targeting potential | Very High | Strong company and title filtering is possible across pharma, biotech, and health-tech segments. |
| Geographic targeting potential | High | Basel attracts Switzerland, DACH, and broader European life sciences accounts. |
| Best outreach approach | Account-based outreach | Target named pharma and biotech accounts with personalized use-case messaging. |
| Overall lead quality | Very High | Strong B2B list-building and enterprise deal-sourcing opportunity. |
| Best use case | Lead generation, speaker targeting, exhibitor sales, and partnership sourcing | Best suited for sales teams selling technology, services, or scientific solutions into life sciences. |
| Limitations / risks | Moderate | Current-year attendee list is not publicly confirmed in the provided content; many targets remain prospecting-based. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals, Biotechnology, Medical Devices, Information Technology & Services, Computer Software, Research, Hospital & Health Care, Management Consulting, Medical Practice | Focus on the highest-probability life sciences and technology buyers. |
| Departments | Procurement, R&D, Research, IT, Data, Digital Transformation, Clinical Operations, Medical Affairs, Business Development | Reach both economic buyers and technical evaluators. |
| Seniority | Manager, Director, VP, SVP, C-Level, Head | Prioritize decision-makers with budget or influence. |
| Job titles | Chief Data Officer, Chief Digital Officer, VP R&D, Procurement Director, Strategic Sourcing Manager, Head of Bioinformatics, Clinical Operations Director, Medical Affairs Director, Business Development Director, Program Manager | Capture the strongest role-based fit for event themes. |
| Geography | Switzerland, Germany, France, Netherlands, Denmark, UK, Nordics, DACH | Reflects Basel’s European life sciences reach. |
| Employee size | 51–200, 201–500, 501–1,000, 1,001–5,000, 5,000+ | Covers both high-growth biotech and large pharma enterprises. |
| Keywords | biotech, pharma, genomics, precision medicine, AI, data science, digital transformation, clinical trials, bioinformatics, diagnostics | Refine records to event-aligned accounts and functions. |
| Technologies | Cloud, data platforms, analytics, AI/ML, laboratory informatics, CRM, ERP, collaboration tools | Useful for selling tech and workflow solutions into life sciences. |
| Company type | Pharma, biotech, diagnostics, research institutions, health data organizations, startups | Aligns with BioTechX participant mix. |
| Revenue / funding | Mid-market and enterprise; venture-backed startups where relevant | Capture both established buyers and innovation-stage targets. |
Suggested Apollo Search Logic: (pharmaceuticals OR biotechnology OR diagnostics OR "medical devices" OR "hospital & health care") AND (procurement OR sourcing OR "digital transformation" OR data OR AI OR bioinformatics OR "clinical operations" OR "medical affairs" OR "business development") AND (director OR VP OR head OR manager OR CDO OR CTO OR CIO).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| BioTechX Europe 2026 official event page | Official organizer source | Dates, venue, city, country, event positioning, attendance, exhibitors, speakers, and official theme | Very High |
| Terrapinn corporate website | Organizer website | Organizer identity and market positioning as a global events company | High |
| Messe Basel | Venue website | Venue name and location context for Basel events | High |
| Official 2026 speaker list shown on event page | Official agenda / speaker roster | Confirmed participating organizations and seniority signals | Very High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to BioTechX Europe — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds